ArticleJACC. Asia2026
Predictors of Bleeding Complications After Extracorporeal Cardiopulmonary Resuscitation: Insights From the SAVE-J II Study.
Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictors of Bleeding After Percutaneous Left Ventricular Assist Device Support: Findings From the J-PVAD Registry.JACC. Advances · 2026Article
- Understanding and Mitigating Bleeding Risks in Extracorporeal Cardiopulmonary Resuscitation.JACC. Asia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExtracorporeal cardiopulmonary resuscitation (ECPR), an emerging resuscitative therapy following refractory cardiac arrests, is associated with hemorrhagic complications that potentially affect patient outcomes.
objectivesThis study evaluated the risks and predictors of hemorrhagic complications among patients who underwent ECPR for out-of-hospital cardiac arrest (OHCA) from different causes.
methodsUsing the SAVE-J II (Study of Advanced Cardiac Life Support for Ventricular Fibrillation with Extracorporeal Circulation in Japan) study, we analyzed multicentric data of patients who underwent ECPR for OHCA from 2013 to 2018 in Japan. Based on the causes of OHCA, the participants were stratified into endogenous cardiac, endogenous noncardiac, and exogenous groups. The primary outcome was any bleeding.
resultsAmong 1,935 patients, 1,417, 305, and 213 patients had endogenous cardiac, endogenous noncardiac, and exogenous causes, respectively. For survivors, the median follow-up period was 36 days, and most of the bleeding events occurred within 1 week post-ECPR. The 30-day cumulative incidence of any bleeding significantly differed among the 3 groups (endogenous cardiac: n = 321 [25.9%]; endogenous noncardiac: n = 41 [18.9%]; and exogenous: n = 27 [13.7%]; P < 0.001). However, the risks for bleeding complications did not differ between the causes of OHCA after adjustment for confounders. Intra-aortic balloon pumping use was associated with higher risks of bleedings and lower risk for all-cause death.
conclusionsUnderlying causes of OHCA did not significantly impact adjusted bleeding risks. Intra-aortic balloon pumping use was independently associated with higher bleeding risks and lower mortality, although this warrants cautious interpretation because of a potential selection bias. Vigilant monitoring for bleeding complications is crucial in ECPR patients, especially in those with additional circulatory support devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.